Clinical Trials in San Francisco

Showing 4061-4080 of 7,248 trials

PAZIT Study for Children and Young Adults With Relapsed or Refractory Sarcoma

NCT03139331

This is the first study to evaluate the safety and clinical activity of the combination of oral pazopanib, intravenous or oral irinotecan, and oral temozolomide in pediatric and young adult patients with relapsed or refractory sarcomas. This study will use a 3 + 3 design for dose escalation (Part 1), followed by an expansion cohort (Part 2) at the recommended phase 2 dose level.

SarcomaRefractory Sarcoma

University of California, San Francisco16 participantsStarted Jun 2017

Oakland, California, United States • San Francisco, California, United States • Boston, Massachusetts, United States

COMPLETEDPhase 2< 1 mile

Efficacy and Safety Study of CSJ148 in Stem Cell Transplant Patients

NCT02268526

This study is designed to test if CSJ148 can prevent HCMV replication after stem cell transplantation.

HCMV

Novartis Pharmaceuticals86 participantsStarted Jun 2015

San Francisco, California, United States • Gainesville, Florida, United States • Beech Grove, Indiana, United States +14 more locations

PAZIT Study for Children and Young Adults With Relapsed or Refractory Sarcoma

Efficacy and Safety Study of CSJ148 in Stem Cell Transplant Patients

Find Trials by Condition in San Francisco

A Study in Maintenance Kidney Transplant Recipients Following Conversion to Nulojix® (Belatacept)-Based

Gliogene: Brain Tumor Linkage Study

A Dose Escalation Study in Solid Tumors and a Dose Expansion Study of PRN1371 in Adult Patients With Metastatic Urothelial Carcinoma

Study of Ibrutinib vs Placebo, in Combination With Nab-paclitaxel and Gemcitabine, in the First Line Treatment of Patients With Metastatic Pancreatic Adenocarcinoma (RESOLVE)

Study of Safety and Efficacy of Brolucizumab 6 mg Drug Product Intended for Commercialization in Patients With nAMD

Study of Efficacy of PEAR-004 in Schizophrenia

Efficacy, Safety and Tolerability of Agomelatine in the Treatment of Major Depressive Disorder

Multicenter Study for Pediatric Subjects Evaluating Pharmacokinetics and Safety of EXPAREL

Efficacy and Safety of AFQ056 When Combined With Increased Doses of L-dopa in Parkinson's Disease Patients With Moderate-severe L-dopa Induced Dyskinesia

Evaluating Anatomic Versus Targeted Lead Placement for Burst Stimulation Therapy During the Trial

Safety and Efficacy Study of Guaifenesin and Pseudoephedrine for Symptomatic Therapy to Treat Acute RTI

Efficacy, Safety and Tolerability of Agomelatine Sublingual Tablets in the Treatment of Major Depressive Disorder

Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma.

Open-label Long Term (52 Weeks) Safety and Tolerability of Agomelatine Sublingual Tablets in Major Depressive Disorder (MDD)

Efficacy, Safety and Tolerability of Agomelatine in the Treatment of Major Depressive Disorder

A Multi-part, Double Blind Study to Assess Safety, Tolerability and Efficacy of Tropifexor (LJN452) in PBC Patients

Study to Promote Innovation in Rural Integrated Telepsychiatry

A Study of CLR325 in Chronic Stable Heart Failure Patients.